Evaluation of VEGF Polymorphism as Predictive Factor in Metastatic Colorectal Cancer Treated With Folfiri Plus Bevacizumab

NCT01363739 · clinicaltrials.gov ↗
UNKNOWN
Status
265
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Azienda Ospedaliero, Universitaria Pisana